Syracuse, NY, United States of America

Jonathan L Miller


Average Co-Inventor Count = 2.4

ph-index = 5

Forward Citations = 77(Granted Patents)


Company Filing History:


Years Active: 1994-2009

Loading Chart...
10 patents (USPTO):Explore Patents

Title: Innovations of Jonathan L Miller

Introduction

Jonathan L Miller is a prominent inventor based in Syracuse, NY (US). He has made significant contributions to the field of biomedical research, particularly in the area of platelet glycoproteins. With a total of 10 patents to his name, Miller's work has the potential to impact medical treatments and therapies.

Latest Patents

Miller's latest patents include groundbreaking inventions such as "Mimotopes and anti-mimotopes of human platelet glycoprotein Ib/IX." This invention focuses on an isolated peptide that mimics a binding site for a monoclonal antibody, which recognizes an epitope within the human platelet glycoprotein Ib/IX complex. Additionally, he has developed methods for selecting clones that bind to human platelet glycoprotein Ib alpha, which can inhibit platelet aggregation. These innovations also encompass isolated nucleic acid molecules and expression vectors that facilitate the production of antibodies targeting human platelet glycoprotein Ib alpha.

Career Highlights

Miller is affiliated with the State University of New York, where he conducts research and develops his inventions. His work has garnered attention for its potential applications in medical science, particularly in improving treatments for conditions related to platelet function.

Collaborations

Some of Miller's notable coworkers include Vicki A Lyle and David Cunningham. Their collaborative efforts contribute to the advancement of research in the field of platelet glycoproteins.

Conclusion

Jonathan L Miller's innovative work in the realm of platelet glycoproteins showcases his dedication to advancing medical science. His patents reflect a commitment to developing solutions that could significantly enhance patient care and treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…